- Cancer Info
- PolyMVA
- PolyMVA for Pets
- Tips for Family and Caregivers
- Patient Checklist
- Glossary of Cancer Terms
- Goodsearch.com
- BuyforCharity.com
- Options for Financial Support
- Participate in a Quality of Life Study
- Press Releases
- Donate
Newsletter
CaringBridge
CaringBridge is a nonprofit organization offering free, personalized websites that allow people to stay in touch with family and friends during a health crisis, treatment and recovery.
Health Search
Brought to you by:
CancerMonthly.com
and
SurvivingMesothelioma.com
Translate
Stories
November 2, 2007
Children whose parents beat certain types of cancer have a better chance of doing the same if they get the disease themselves, according to a Swedish study suggesting that survival traits are passed on.
The research, published in the November issue of Lancet Oncology, said good survival -- defined as living for at least 10 years past the cancer diagnosis -- extended to breast, lung, prostate and colorectal cancers.
Both genetic and environmental factors likely...
Read More...
Read More...
Medical News Today
October 31, 2007
A five day course of radiotherapy to treat breast cancer may, in some cases, expose as much lung and heart tissue to potentially toxic radiation as does the standard six weeks of treatment, say researchers at Mayo Clinic Jacksonville.
That because the short treatment, known as partial breast irradiation, focus radiation to a small sector of the breast through multiple beams, these beams can pass through the breast to the heart and lungs that...
Read More...
Read More...
November 9, 2007
The Food and Drug Administration called on physicians Thursday to warn cancer patients undergoing chemotherapy that certain anti-anemia drugs led to tumor growth and decreased survival in some patients.
At issue are drugs sold under the brand names Procrit, Epogen and Aranesp. These drugs are genetically engineered versions of a natural protein that increases the number of red blood cells. The drugs generated $10 billion in sales last year.
The FDA said on...
Read More...
Read More...
Breast cancer survivors may face increased risk of heart disease — and doctors are debating if it's time to largely abandon a chemotherapy mainstay that is one reason for the problem.
Drugs called anthracyclines are a breast chemo staple despite a well-known risk: They weaken some women's hearts. What's new is research suggesting the drugs work no better than safer alternatives for most women.
It's a controversy born of success: Treatment advances are enabling more women than ever...
Read More...
Read More...
In another blow to the use of chemotherapy in the treatment of lung cancer, researchers at the National Bureau of Economic Research have found that chemotherapy for non-small cell lung cancer (NSCLC) in people 65 and older has a minimal impact on survival.
Rebecca M. Woodward, PhD, a former research associate at Harvard University, used US government data to calculate the life expectancy of patients after they received a diagnosis of lung cancer. She and her colleagues combined...
Read More...
Read More...
By Kelly Corrigan
5 ways to help a friend with cancer - even if it scares the heck out of you
I bet you know me. I'm the friend who bought you a really funny birthday card, but when your big day came around I couldn't find it, so I whipped off an e-mail instead. Oh, and when you called, I meant to ask about your mom's knee surgery, but I started blabbing about how I got another parking ticket. Then I volunteered to bring homemade cookies to the team party and...
Read More...
Read More...
Researchers say they have now identified the mechanism of action of lipoic acid, a remarkable compound that in animal experiments appears to slow down the process of aging, improve blood flow, enhance immune function and perform many other functions.
The findings, discussed at the “Diet and Optimum Health” conference sponsored by The Linus Pauling Institute at Oregon State University, shed light on how this micronutrient might perform such a wide range of beneficial functions.
“The...
Read More...
Read More...
Exposure in childhood is key, quintupling the risk among women with high levels of the pesticide, researchers say.
Women heavily exposed to the pesticide DDT during childhood are five times as likely to develop breast cancer, a new scientific study suggests.
For decades, scientists have tried to determine whether there is a connection between breast cancer and DDT, the most widely used insecticide in history. The UC Berkeley research, based on a small number of Bay...
Read More...
Read More...
In the late 1990s, citizens of several European countries learned from newspaper reports that their infants were constantly being exposed to a host of toxic chemicals. Babies were sleeping in pajamas treated with cancer-causing flame retardants; they were sucking on bottles laced with plastic additives believed to alter hormones; their diapers were glued together with nerve-damaging toxins normally used to kill algae on the hulls of ships. When European health officials tried to look...
Read More...
Read More...
The average mouse doesn't care much about skin cancer. Outside of Disney cartoons, you won't see one slathering on sunscreen before heading out to dodge cats and search for cheese. But Gary Stoner, Ph.D., a professor emeritus of hematology and oncology at the Ohio State University medical center, does care about cancer. That's why he spends his days in a lab, feeding rodents polyphenols from seaweed and learning how to shrink skin cancer–like tumors. He's a mouse's best friend. Maybe...
Read More...
Read More...